Citation Impact
Citing Papers
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
2008 Standout
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction
1997
Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure
1998
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
2002 Standout
Relation of Loop Diuretic Dose to Mortality in Advanced Heart Failure
2006
Long-Term Trends in the Incidence of and Survival with Heart Failure
2002 Standout
Arrhythmias and mortality in congestive heart failure
1990
Guidelines for the diagnosis and treatment of chronic heart failure
2001
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Clinical Efficacy of Sitaxsentan, an Endothelin-A Receptor Antagonist, in Patients With Pulmonary Arterial Hypertension
2002
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Unstable angina: Pathogenesis, diagnosis, and treatment
1993
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
2003 Standout
Treatment of Pulmonary Arterial Hypertension
2004 Standout
The Failing Heart — An Engine Out of Fuel
2007 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Effect of Thyroid Hormones on Cardiac Function, Geometry, and Oxidative Metabolism Assessed Noninvasively by Positron Emission Tomography and Magnetic Resonance Imaging
2000
B-type natriuretic peptide levels: A potential novel “white count” for congestive heart failure
2001
Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease
2001
Valsartan in heart failure patients previously untreated with an ACE inhibitor
1998
Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction
2001
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Effects of Vesnarinone on Morbidity and Mortality in Patients with Heart Failure
1993
Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: Safety and cost efficacy
1997
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Aldosterone and antialdosterone therapy in congestive heart failure
1993
Bedside diagnosis of preserved versus impaired left ventricular systolic function in heart failure
1991
Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure
1999
Aldosterone-Induced Inflammation in the Rat Heart
2002
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
2007
Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure
2002
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
1997
Thyroid Hormone and the Cardiovascular System
2001 Standout
Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
1998
Social Relationships and Mortality Risk: A Meta-analytic Review
2010 Standout
Optimal Pharmacologic and Non-pharmacologic Management of Cardiac Transplant Candidates: Approaches to Be Considered Prior to Transplant Evaluation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006
2006
Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials
2002
Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia
1995
Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease
1998
Levosimendan, a New Calcium‐Sensitizing Inotrope for Heart Failure
2004
Causes of congestive heart failure
1997
Hormones and Hemodynamics in Heart Failure
1999
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Complex heart rate variability and serum norepinephrine levels in patients with advanced heart failure
1994
Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure
1993
G protein‐coupled receptor signalling in in vivo cardiac overload
2001
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
1996 Standout
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction.
1995
Randomised trial of low-dose amiodarone in severe congestive heart failure
1994
Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled study
1994
A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study
2001 Standout
Early Ultrafiltration in Patients With Decompensated Heart Failure and Diuretic Resistance
2005
Ventricular Dilatation and Remodeling After Myocardial Infarction
1994
Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study
1998
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
2002 Standout
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure<SUBTITLE>The EVEREST Outcome Trial</SUBTITLE>
2007 Standout
Nonparallel changes in global left ventricular chamber volume and muscle mass during the first year after transmural myocardial infarction in humans
1993
Natriuretic Peptides
1998 Standout
Hostile Marital Interactions, Proinflammatory Cytokine Production, and Wound Healing
2005
Improving survival for patients with advanced heart failure: A study of 737 consecutive patients
1995
Marital Status, Marital Strain, and Risk of Coronary Heart Disease or Total Mortality: The Framingham Offspring Study
2007
Myocardial Reperfusion Injury
2007 Standout
Left Ventricular Remodeling With Carvedilol in Patients With Congestive Heart Failure Due to Ischemic Heart Disease fn1fn1This study was funded by a grant from SmithKline Beecham; however, the study was initiated, conducted, analyzed and reported by the Australia–New Zealand Heart Failure Research Collaborative Group independently of the sponsor. The Clinical Trials Research Unit is supported by a programme grant from the Health Research Council of New Zealand.
1997
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure*
1995
Effects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized With Worsening Heart Failure<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2004
Direct Inhibition of Type 5 Adenylyl Cyclase Prevents Myocardial Apoptosis without Functional Deterioration
2004
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)
1996
The pathophysiology of acute heart failure—Is it all about fluid accumulation?
2007
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)
1999
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Proarrhythmia with Class III Antiarrhythmic Drugs: Definition, Electrophysiologic Mechanisms, Incidence, Predisposing Factors, and Clinical Implications
1995
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
2012 Standout
Rationale and Design of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)
2005
Detection of anthracycline-induced cardiotoxicity
1999
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 Standout
Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registry
1996
Contracted plasma and blood volume in chronic heart failure
2000
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
2005 Standout
Congestive Heart Failure: Potential Role of Arginine Vasopressin Antagonists in the Therapy of Heart Failure
2002
Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure
2007
Activation of neurohumoral systems following acute myocardial infarction
1991
Predictors of prognosis in severe chronic heart failure
1992
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
2005 Standout
Vasopressin receptor antagonists
2006
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Acute Hemodynamic Effects of Conivaptan, a Dual V 1A and V 2 Vasopressin Receptor Antagonist, in Patients With Advanced Heart Failure
2001
Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety
2012
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Effects of Long-term Enalapril Therapy on Cardiac Structure and Function in Patients With Left Ventricular Dysfunction
1995
Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group.
1991
Social Relations and Mortality
2010
Acute Hemodynamic Interaction of Aspirin and Ticlopidine With Enalapril
1998
Measurement and significance of circulating natriuretic peptides in cardiovascular disease
1998
Diuretic Treatment for the Sodium Retention of Congestive Heart Failure
1994
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Pulmonary Arterial Hypertension
2006
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
1998 Standout
Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes
2006 StandoutNobel
The Limited Reliability of Physical Signs for Estimating Hemodynamics in Chronic Heart Failure
1989
B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction
2003
Plasma N-Terminal Pro–Brain Natriuretic Peptide and Adrenomedullin
1998
Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart Failure
1997
Unstable angina. A classification.
1989
Neurohumoral Prediction of Benefit From Carvedilol in Ischemic Left Ventricular Dysfunction
1999
?Escape? of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapy
1995
Molecular and Cellular Mechanisms of Myocardial Stunning
1999
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
1996
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure.
1992
An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
1993 Standout
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group.
1994
Heart Rate Variability
1996 Standout
Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
1996 Standout
Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure
1998
Improvement in Exercise Tolerance and Symptoms of Congestive Heart Failure During Treatment With Candesartan Cilexetil
1999
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
1993
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
Level of β-Adrenergic Receptor Kinase 1 Inhibition Determines Degree of Cardiac Dysfunction After Chronic Pressure Overload–Induced Heart Failure
2005 StandoutNobel
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
1994
Brain natriuretic peptide predicts mortality in the elderly.
1997
Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure
1999
Works of John M. Nicklas being referenced
Effects of repeated brief coronary occlusion on regional left ventricular function and dimension in dogs
1985
Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy
1991
Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: Results of a randomized, double-blind, placebo-controlled trial
1988
The effects of afterload reduction on myocardial carbon 11-labeled acetate kinetics and noninvasively estimated mechanical efficiency in patients with dilated cardiomyopathy
1994
Prognostic importance of marital quality for survival of congestive heart failure
2001
Effectiveness of imazodan for treatment of chronic congestive heart failure
1991
Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with congestive heart failure
1988
Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: A report from the registry of studies of left ventricular dysfunction
1994
Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction
1995
Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: Results of the studies of left ventricular dysfunctions (SOLVD) registry
1993
Randomized, double-blind, placebo-controlled trial of tissue plasminogen activator in unstable angina
1989
Neurohumoral variability in left ventricular dysfunction
1995
Acute Endothelin A Receptor Blockade Causes Selective Pulmonary Vasodilation in Patients With Chronic Heart Failure
2000
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
1990 Standout
Prediction of left ventricular ejection fraction using simple
1986
Effects of intravenous levosimendan on plasma neurohormone levels in patients with heart failure: relation to hemodynamic response
1999
Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure
2000